Skip to main content

Published locations for One in four NSCLC patients respond poorly to COVID-19 vaccine

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. One in four NSCLC patients respond poorly to COVID-19 vaccine

User login

  • Reset your password
  • /content/one-four-nsclc-patients-respond-poorly-covid-19-vaccine
  • /fedprac/article/256785/lung-cancer/one-four-nsclc-patients-respond-poorly-covid-19-vaccine
  • /internalmedicinenews/article/256785/lung-cancer/one-four-nsclc-patients-respond-poorly-covid-19
  • /oncologypractice/article/256785/lung-cancer/one-four-nsclc-patients-respond-poorly-covid-19-vaccine
  • /fedprac/avaho/article/256785/lung-cancer/one-four-nsclc-patients-respond-poorly-covid-19-vaccine
  • /hematology-oncology/article/256785/lung-cancer/one-four-nsclc-patients-respond-poorly-covid-19
  • /internalmedicine/article/256785/lung-cancer/one-four-nsclc-patients-respond-poorly-covid-19-vaccine
  • /chestphysician/article/256785/lung-cancer/one-four-nsclc-patients-respond-poorly-covid-19-vaccine
  • /breast-cancer-icymi/article/256785/lung-cancer/one-four-nsclc-patients-respond-poorly-covid-19
  • /b-cell-lymphoma-icymi/article/256785/lung-cancer/one-four-nsclc-patients-respond-poorly-covid-19